Indrayani Biotech Ltd () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Nirman Agri

Himalaya Food

Universal Starch

Kohinoor Foods

Flex Foods

Annvrridhhi Ven

Unique Organics

Indrayani Biotec

Raghuvansh Agro.

Gujarat Peanut

Agri-Tech India

Why is Indrayani Biotech Ltd ?

Weak Long Term Fundamental Strength with a -253.18% CAGR growth in Operating Profits over the last 5 years

Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.34 times
The company has been able to generate a Return on Capital Employed (avg) of 7.90% signifying low profitability per unit of total capital (equity and debt)

The company has declared Negative results for the last 5 consecutive quarters

PBT LESS OI(Q) At Rs -0.85 cr has Fallen at -194.44%
PAT(Q) At Rs 0.16 cr has Fallen at -81.2%
ROCE(HY) Lowest at -2.00%

Risky - Negative Operating Profits

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -61.14%, its profits have fallen by -166.3%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -61.14% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Indrayani Biotec for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Indrayani Biotec

-61.14%

-1.21

50.37%

Sensex

4.74%

0.39

11.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

41.38%

EBIT Growth (5y)

-253.18%

EBIT to Interest (avg)

0.48

Debt to EBITDA (avg)

4.34

Net Debt to Equity (avg)

1.89

Sales to Capital Employed (avg)

1.00

Tax Ratio

4.94%

Dividend Payout Ratio

Pledged Shares

2.46%

Institutional Holding

3.13%

ROCE (avg)

6.27%

ROE (avg)

10.51%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.88

EV to EBIT

-22.22

EV to EBITDA

23.28

EV to Capital Employed

0.96

EV to Sales

1.57

PEG Ratio

Dividend Yield

ROCE (Latest)

-3.49%

ROE (Latest)

-9.42%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bullish

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-17What is not working for the Company

PBT LESS OI(Q)

At Rs -0.85 cr has Fallen at -194.44%

PAT(Q)

At Rs 0.16 cr has Fallen at -81.2%

ROCE(HY)

Lowest at -2.00%

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.15 times

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 0.29 cr

DEBT-EQUITY RATIO(HY)

Highest at 1.89 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.22 times

NET SALES(Q)

At Rs 29.10 cr has Grown at -7.71%

NON-OPERATING INCOME(Q)

is 504.76 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is not working for Indrayani Biotec

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs -0.85 cr has Fallen at -194.44%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 0.16 cr has Fallen at -81.2%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)

Inventory Turnover Ratio- Half Yearly

Lowest at 3.15 times and Fallen

each half year in the last five half yearly periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales - Quarterly

At Rs 29.10 cr has Grown at -7.71%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (Rs Cr)

Non Operating Income - Quarterly

is 504.76 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Cash and Cash Equivalents - Half Yearly

Lowest at Rs 0.29 cr

in the last six half yearly periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio - Half Yearly

Highest at 1.89 times

in the last five half yearly periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly

Lowest at 2.22 times

in the last five half yearly periods

MOJO Watch

Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio